Search - tctmd.com

Displaying 961 - 980 of 1054

Sort: Relevancy | Date

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

September 02, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Quitting Smoking After PCI Can Add Years to Patients’ Lives

L.A. McKeown

August 05, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

Study Questions Routine Stress Testing in Chest Pain Units

Caitlin E. Cox

June 28, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Daily News

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

L.A. McKeown

March 25, 2013

News Daily News

Study Highlights Gender Differences in Bleeding Risk After PCI

L.A. McKeown

March 25, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

Presentation TCT 2013

Comparison of Target Lesion and Vessel Revascularization in Women of Different Age Groups after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Presenter: Soha Ahmad, Omid Fatemi, Rebecca Torguson, Joseph Lindsay, Ron Waksman

January 31, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

News Daily News

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

L.A. McKeown

January 13, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

Advertisement

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Quitting Smoking After PCI Can Add Years to Patients’ Lives

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Study Questions Routine Stress Testing in Chest Pain Units

SES Show Advantage Over ZES, PES for Diabetic Patients

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

Study Highlights Gender Differences in Bleeding Risk After PCI

Remote Postconditioning Reduces AKI in NSTEMI Patients

Comparison of Target Lesion and Vessel Revascularization in Women of Different Age Groups after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content